Chemours (CC) PT Lowered to $15 at Morgan Stanley
Tweet
Share
E-mailGet Alerts CC Hot Sheet
Price: $15.97 +1.78%
Rating Summary:
9 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
9 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Morgan Stanley analyst Vincent Andrews lowered the price target on Chemours (NYSE: CC) to $15.00 (from $22.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Viking Holdings (VIK) PT Raised to $82 at Mizuho
- Bill.com Holdings Inc. (BILL) PT Raised to $59 at TD Cowen
- Progyny (PGNY) PT Raised to $30 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
